Bush NR, Aschbacher K. Immune Biomarkers of Early-Life Adversity and Exposure to Stress and Violence—Searching Outside the Streetlight. JAMA Pediatr. 2020;174(1):17–19. doi:10.1001/jamapediatrics.2019.3882

Raman spectroscopyinstrumentation

Welcome to the RRUFF Project website containing an integrated database of Raman spectra, X-ray diffraction and chemistry data for minerals.

Raman spectroscopyPDF

© 2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. Terms of Use| Privacy Policy| Accessibility Statement| Cookie Settings

Evidence of an association between early-life adversity and heightened risk of chronic disease in adulthood has been found, but the optimal biomarkers for identifying vulnerable or resilient individuals remain unclear.1 Global trends, including widening socioeconomic disparities, the refugee crises, and climate change, increasingly sculpt trauma exposure and call for scalable early-risk identification and treatment strategies. Pediatricians often serve on the frontline of early identification and treatment of at-risk children, intervening during crucial windows of opportunity to prevent longer-term bioembedding that confers risk of disease across the life course. However, problems of scale need solutions that scale, which is one reason why the discoveries by Rasmussen et al,2 reported in this issue, represent a promising step forward. Using high-quality assessments of multidomain, multireporter adversity exposure, these investigators present prospective, longitudinal evidence from a large, socioeconomically diverse sample that soluble urokinase plasminogen activator receptor (suPAR) may be a useful immune biomarker of early-life adversity, having a stronger and more exposure-specific association than current clinical markers, such as C-reactive protein. This type of rigorous epidemiologic “big data” work, complemented with “deep data,” will accelerate biomarker discovery for clinical diagnosis and treatment of early risk and resilience profiles and provide the foundation for precision medicine strategies in pediatrics.

The RRUFF™ Project is creating a complete set of high quality spectral data from well characterized minerals and is developing the technology to share this information with the world. Our collected data provides a standard for mineralogists, geoscientists, gemologists and the general public for the identification of minerals both on earth and for planetary exploration. more info...